What are the diagnostic tests and management options for vasospastic angina?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Tests for Vasospastic Angina

Obtain a 12-lead ECG during an angina episode to document transient ST-segment changes (elevation or depression), which is the cornerstone of vasospastic angina diagnosis. 1

Initial Non-Invasive Diagnostic Approach

ECG Documentation During Symptoms

  • Capture a 12-lead ECG during chest pain episodes to identify transient ischemic ST-segment changes that occur at rest, typically at normal heart rate 1
  • Prinzmetal angina specifically shows transient ST-segment elevation during resting angina attacks, correlating with proximal vessel occlusion 1
  • ST-segment changes must resolve with nitrates and/or calcium channel blockers to support the diagnosis 1

Ambulatory ECG Monitoring

  • Use 12-lead ambulatory ECG monitoring (Holter) when vasospastic angina is suspected but ECG changes haven't been captured during symptoms 1
  • ST-segment shifts occurring at normal heart rate (without tachycardia) strongly support myocardial ischemia from spasm rather than demand ischemia 1
  • Extended Holter monitoring for >1 week may be required since most vasospastic attacks are self-limiting and documentation can be challenging 1
  • Ambulatory monitoring also assesses treatment efficacy by tracking frequency of vasospastic events 1

Invasive Diagnostic Testing

Coronary Angiography

  • Perform invasive coronary angiography or coronary CTA in all patients with characteristic episodic resting angina and documented ST-segment changes to determine the extent of underlying fixed coronary disease 1
  • This is a Class I, Level C recommendation from the European Society of Cardiology 1

Intracoronary Provocation Testing

Intracoronary provocation testing with acetylcholine or ergonovine should be performed in patients with normal or non-obstructive coronary arteries on angiography who have a clinical picture consistent with coronary spasm (Class IIa, Level B recommendation) 1

Test Protocol and Interpretation

  • Intracoronary acetylcholine or ergonovine are the preferred provocative agents due to low sensitivity of hyperventilation and cold pressor tests 1
  • A positive provocation test requires all three components: (1) anginal symptoms, (2) ischemic ECG changes, and (3) severe vasoconstriction of the epicardial vessel 1
  • If the test fails to trigger all three components, it should be considered equivocal 1
  • Both agents are safe when selectively infused into the left or right coronary artery, with triggered spasm readily controlled by intracoronary nitrates 1

Safety Profile

  • Ventricular tachycardia/fibrillation occurs in 3.2% and bradyarrhythmias in 2.7% during provocation testing, similar to rates during spontaneous spasm attacks (7%) 1

Microvascular Assessment

  • Intracoronary acetylcholine with ECG monitoring may be considered (Class IIb, Level B) to assess microvascular vasospasm in patients with angiographically normal or moderate stenoses with preserved iwFR/FFR 1
  • Angina developing in response to acetylcholine without angiographically evident spasm (with or without ST-segment changes) may indicate microvascular spasm 1
  • Guidewire-based coronary flow reserve (CFR) and/or microcirculatory resistance measurements should be considered (Class IIa, Level B) in patients with persistent symptoms but normal or non-obstructive coronary arteries 1

Diagnostic Algorithm

  1. First-line: Attempt to capture 12-lead ECG during spontaneous angina episode 1
  2. If ECG not captured during symptoms: Deploy 12-lead ambulatory Holter monitoring, potentially for >1 week 1
  3. Once transient ST-segment changes documented: Proceed to invasive angiography or coronary CTA to exclude fixed obstructive disease 1
  4. If coronary arteries are normal or show non-obstructive lesions: Perform intracoronary provocation testing with acetylcholine or ergonovine to confirm diagnosis and identify spasm location 1
  5. If epicardial spasm testing is negative but symptoms persist: Consider microvascular assessment with CFR/microcirculatory resistance measurements or acetylcholine testing for microvascular spasm 1

Common Pitfalls to Avoid

  • Do not rely on exercise testing alone, as vasospastic angina typically occurs at rest with preserved exercise capacity 2, 3
  • Do not dismiss normal coronary angiography as excluding cardiac causes—proceed to provocation testing in appropriate clinical context 1
  • Do not accept incomplete provocation test results—all three criteria (symptoms, ECG changes, and angiographic spasm) must be present for a positive test 1
  • Recognize that vasospastic angina is underdiagnosed because provocation testing is rarely performed despite being the gold standard 2, 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Vasospastic angina: A literature review of current evidence.

Archives of cardiovascular diseases, 2019

Research

Vasospastic angina: a review on diagnostic approach and management.

Therapeutic advances in cardiovascular disease, 2024

Research

Vasospastic angina: Past, present, and future.

Pharmacology & therapeutics, 2023

Research

Management of vasospastic angina.

Heart (British Cardiac Society), 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.